ResMed Inc. (0KW4.L)
USD 233.41
(-3.67%)
USD 233.41
(-3.67%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 2.6 Billion USD | 12.72% |
| 2023 | 2.35 Billion USD | 16.37% |
| 2022 | 2.02 Billion USD | 10.07% |
| 2021 | 1.83 Billion USD | 7.06% |
| 2020 | 1.71 Billion USD | 11.79% |
| 2019 | 1.53 Billion USD | 12.8% |
| 2018 | 1.36 Billion USD | 13.35% |
| 2017 | 1.2 Billion USD | 12.68% |
| 2016 | 1.06 Billion USD | 5.45% |
| 2015 | 1.01 Billion USD | 2.18% |
| 2014 | 989.78 Million USD | 5.22% |
| 2013 | 940.65 Million USD | 14.61% |
| 2012 | 820.73 Million USD | 10.71% |
| 2011 | 741.32 Million USD | 13.1% |
| 2010 | 655.48 Million USD | 18.36% |
| 2009 | 553.8 Million USD | 12.16% |
| 2008 | 493.75 Million USD | 28.42% |
| 2007 | 384.49 Million USD | 2.02% |
| 2006 | 376.89 Million USD | 37.12% |
| 2005 | 274.86 Million USD | 26.82% |
| 2004 | 216.73 Million USD | 25.22% |
| 2003 | 173.08 Million USD | 29.9% |
| 2002 | 133.24 Million USD | 27.17% |
| 2001 | 104.77 Million USD | 23.46% |
| 2000 | 84.87 Million USD | 33.03% |
| 1999 | 63.8 Million USD | 35.46% |
| 1998 | 47.1 Million USD | 49.52% |
| 1997 | 31.5 Million USD | 66.67% |
| 1996 | 18.9 Million USD | 47.66% |
| 1995 | 12.8 Million USD | 60.0% |
| 1994 | 8 Million USD | 66.67% |
| 1993 | 4.8 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 FY | 2.6 Billion USD | 10.75% |
| 2024 Q2 | 646.93 Million USD | 7.81% |
| 2024 Q1 | 600.06 Million USD | -2.81% |
| 2024 Q4 | 704.26 Million USD | 3.33% |
| 2024 Q3 | 681.57 Million USD | 5.35% |
| 2023 Q2 | 579.71 Million USD | 7.19% |
| 2023 FY | 2.35 Billion USD | 16.37% |
| 2023 Q4 | 617.38 Million USD | -0.06% |
| 2023 Q1 | 540.81 Million USD | 3.5% |
| 2023 Q3 | 617.75 Million USD | 6.56% |
| 2022 Q1 | 506.28 Million USD | 3.18% |
| 2022 FY | 2.02 Billion USD | 10.07% |
| 2022 Q4 | 522.5 Million USD | 6.37% |
| 2022 Q3 | 491.19 Million USD | -2.6% |
| 2022 Q2 | 504.31 Million USD | -0.39% |
| 2021 Q1 | 438.66 Million USD | -2.38% |
| 2021 Q3 | 447.25 Million USD | -3.29% |
| 2021 FY | 1.83 Billion USD | 7.06% |
| 2021 Q2 | 462.48 Million USD | 5.43% |
| 2021 Q4 | 490.69 Million USD | 9.71% |
| 2020 Q2 | 427.13 Million USD | 5.45% |
| 2020 Q4 | 449.37 Million USD | -0.06% |
| 2020 FY | 1.71 Billion USD | 11.79% |
| 2020 Q3 | 449.66 Million USD | 5.28% |
| 2020 Q1 | 405.05 Million USD | -3.06% |
| 2019 Q2 | 383.73 Million USD | 11.84% |
| 2019 Q4 | 417.85 Million USD | 6.62% |
| 2019 Q1 | 343.09 Million USD | -5.35% |
| 2019 Q3 | 391.91 Million USD | 2.13% |
| 2019 FY | 1.53 Billion USD | 12.8% |
| 2018 Q2 | 349.79 Million USD | 14.46% |
| 2018 FY | 1.36 Billion USD | 13.35% |
| 2018 Q4 | 362.47 Million USD | 5.28% |
| 2018 Q1 | 305.6 Million USD | -5.61% |
| 2018 Q3 | 344.29 Million USD | -1.57% |
| 2017 Q3 | 299.71 Million USD | -3.03% |
| 2017 Q2 | 309.07 Million USD | 14.82% |
| 2017 Q4 | 323.77 Million USD | 8.03% |
| 2017 FY | 1.2 Billion USD | 12.68% |
| 2017 Q1 | 269.18 Million USD | -10.72% |
| 2016 Q3 | 259.88 Million USD | -2.49% |
| 2016 Q2 | 266.5 Million USD | 11.69% |
| 2016 Q1 | 238.61 Million USD | -8.02% |
| 2016 FY | 1.06 Billion USD | 5.45% |
| 2016 Q4 | 301.48 Million USD | 16.01% |
| 2015 FY | 1.01 Billion USD | 2.18% |
| 2015 Q4 | 259.43 Million USD | 3.18% |
| 2015 Q3 | 251.43 Million USD | -4.48% |
| 2015 Q1 | 237.31 Million USD | -9.17% |
| 2015 Q2 | 263.22 Million USD | 10.92% |
| 2014 Q4 | 261.25 Million USD | 3.76% |
| 2014 Q2 | 248.75 Million USD | 9.11% |
| 2014 Q1 | 227.98 Million USD | -12.26% |
| 2014 FY | 989.78 Million USD | 5.22% |
| 2014 Q3 | 251.78 Million USD | 1.22% |
| 2013 Q1 | 208.64 Million USD | -7.87% |
| 2013 Q4 | 259.84 Million USD | 8.52% |
| 2013 FY | 940.65 Million USD | 14.61% |
| 2013 Q3 | 239.44 Million USD | 2.89% |
| 2013 Q2 | 232.71 Million USD | 11.53% |
| 2012 Q3 | 210.49 Million USD | 5.93% |
| 2012 Q4 | 226.46 Million USD | 7.59% |
| 2012 Q1 | 185.05 Million USD | -6.95% |
| 2012 Q2 | 198.71 Million USD | 7.38% |
| 2012 FY | 820.73 Million USD | 10.71% |
| 2011 Q2 | 185.99 Million USD | 6.92% |
| 2011 Q1 | 173.95 Million USD | -0.32% |
| 2011 FY | 741.32 Million USD | 13.1% |
| 2011 Q4 | 198.87 Million USD | -63.34% |
| 2011 Q3 | 542.45 Million USD | 191.64% |
| 2010 Q3 | 166.58 Million USD | 1.45% |
| 2010 Q2 | 164.2 Million USD | 9.34% |
| 2010 Q1 | 150.17 Million USD | -4.17% |
| 2010 FY | 655.48 Million USD | 18.36% |
| 2010 Q4 | 174.51 Million USD | 4.76% |
| 2009 Q3 | 138.94 Million USD | 6.04% |
| 2009 Q2 | 131.02 Million USD | 3.07% |
| 2009 Q1 | 127.12 Million USD | -5.19% |
| 2009 FY | 553.8 Million USD | 12.16% |
| 2009 Q4 | 156.7 Million USD | 12.79% |
| 2008 Q1 | 111.77 Million USD | -4.63% |
| 2008 FY | 493.75 Million USD | 28.42% |
| 2008 Q4 | 134.08 Million USD | 5.95% |
| 2008 Q3 | 126.55 Million USD | 4.31% |
| 2008 Q2 | 121.33 Million USD | 8.55% |
| 2007 Q1 | 101.29 Million USD | -2.77% |
| 2007 FY | 384.49 Million USD | 2.02% |
| 2007 Q3 | 54.23 Million USD | -51.47% |
| 2007 Q2 | 111.75 Million USD | 10.33% |
| 2007 Q4 | 117.2 Million USD | 116.12% |
| 2006 Q2 | 91.72 Million USD | 14.49% |
| 2006 FY | 376.89 Million USD | 37.12% |
| 2006 Q1 | 80.11 Million USD | 0.43% |
| 2006 Q4 | 104.18 Million USD | 3.29% |
| 2006 Q3 | 100.86 Million USD | 9.96% |
| 2005 Q2 | 68.37 Million USD | 21.21% |
| 2005 Q4 | 79.77 Million USD | 13.49% |
| 2005 FY | 274.86 Million USD | 26.82% |
| 2005 Q3 | 70.29 Million USD | 2.8% |
| 2005 Q1 | 56.41 Million USD | -5.36% |
| 2004 Q4 | 59.6 Million USD | 3.57% |
| 2004 Q1 | 47.15 Million USD | -6.37% |
| 2004 Q3 | 57.55 Million USD | 9.78% |
| 2004 FY | 216.73 Million USD | 25.22% |
| 2004 Q2 | 52.42 Million USD | 11.17% |
| 2003 Q1 | 37.69 Million USD | 2.42% |
| 2003 Q3 | 43.18 Million USD | 3.22% |
| 2003 Q2 | 41.83 Million USD | 10.99% |
| 2003 FY | 173.08 Million USD | 29.9% |
| 2003 Q4 | 50.36 Million USD | 16.62% |
| 2002 Q2 | 31.83 Million USD | 3.26% |
| 2002 Q4 | 36.8 Million USD | 8.99% |
| 2002 FY | 133.24 Million USD | 27.17% |
| 2002 Q3 | 33.77 Million USD | 6.07% |
| 2002 Q1 | 30.83 Million USD | 18.41% |
| 2001 Q2 | 24.8 Million USD | 7.59% |
| 2001 Q4 | 26.04 Million USD | -15.7% |
| 2001 FY | 104.77 Million USD | 23.46% |
| 2001 Q1 | 23.05 Million USD | 0.48% |
| 2001 Q3 | 30.88 Million USD | 24.55% |
| 2000 Q1 | 19.1 Million USD | 6.7% |
| 2000 Q2 | 21 Million USD | 9.95% |
| 2000 Q4 | 22.94 Million USD | 5.34% |
| 2000 Q3 | 21.77 Million USD | 3.71% |
| 2000 FY | 84.87 Million USD | 33.03% |
| 1999 Q4 | 17.9 Million USD | 11.88% |
| 1999 FY | 63.8 Million USD | 35.46% |
| 1999 Q1 | 14.1 Million USD | 2.17% |
| 1999 Q2 | 15.6 Million USD | 10.64% |
| 1999 Q3 | 16 Million USD | 2.56% |
| 1998 Q1 | 9.5 Million USD | 3.26% |
| 1998 Q4 | 13.8 Million USD | 13.11% |
| 1998 Q3 | 12.2 Million USD | 5.17% |
| 1998 Q2 | 11.6 Million USD | 22.11% |
| 1998 FY | 47.1 Million USD | 49.52% |
| 1997 Q2 | 7.5 Million USD | 11.94% |
| 1997 Q1 | 6.7 Million USD | 8.06% |
| 1997 Q3 | 8.1 Million USD | 8.0% |
| 1997 Q4 | 9.2 Million USD | 13.58% |
| 1997 FY | 31.5 Million USD | 66.67% |
| 1996 FY | 18.9 Million USD | 47.66% |
| 1996 Q4 | 6.2 Million USD | 29.17% |
| 1996 Q3 | 4.8 Million USD | -39.24% |
| 1996 Q1 | 6.7 Million USD | 0.0% |
| 1996 Q2 | 7.9 Million USD | 17.91% |
| 1995 Q1 | 5.6 Million USD | 64.71% |
| 1995 Q3 | 5.6 Million USD | 0.0% |
| 1995 Q4 | 6.7 Million USD | 19.64% |
| 1995 FY | 12.8 Million USD | 60.0% |
| 1995 Q2 | 5.6 Million USD | 0.0% |
| 1994 FY | 8 Million USD | 66.67% |
| 1994 Q4 | 3.4 Million USD | -2.86% |
| 1994 Q2 | 3.5 Million USD | 0.0% |
| 1994 Q1 | 3.5 Million USD | 75.0% |
| 1994 Q3 | 3.5 Million USD | 0.0% |
| 1993 Q1 | 1.9 Million USD | 0.0% |
| 1993 Q4 | 2 Million USD | 5.26% |
| 1993 Q3 | 1.9 Million USD | 0.0% |
| 1993 Q2 | 1.9 Million USD | 0.0% |
| 1993 FY | 4.8 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Phreesia, Inc. | 201.74 Million USD | -1193.109% |
| Accuray Incorporated | 143.12 Million USD | -1722.781% |
| Align Technology, Inc. | 2.72 Billion USD | 4.095% |
| Elevance Health Inc. | 47.01 Billion USD | 94.451% |
| AxoGen, Inc. | 127.87 Million USD | -1940.119% |
| Boston Scientific Corporation | 9.84 Billion USD | 73.512% |
| CVS Health Corporation | 54.43 Billion USD | 95.207% |
| Cardinal Health, Inc. | 7.41 Billion USD | 64.813% |
| Centene Corporation | 153.99 Billion USD | 98.306% |
| DaVita Inc. | 3.82 Billion USD | 31.715% |
| HCA Healthcare, Inc. | 55.06 Billion USD | 95.262% |
| Hologic, Inc. | 2.23 Billion USD | -16.578% |
| Humana Inc. | 106.44 Billion USD | 97.549% |
| IDEXX Laboratories, Inc. | 2.18 Billion USD | -19.124% |
| Laboratory Corporation of America Holdings | 3.36 Billion USD | 22.471% |
| Masimo Corporation | 1 Billion USD | -159.968% |
| McKesson Corporation | 12.58 Billion USD | 79.269% |
| Patterson Companies, Inc. | 1.38 Billion USD | -89.009% |
| Quest Diagnostics Incorporated | 2.96 Billion USD | 11.895% |
| Henry Schein, Inc. | 3.65 Billion USD | 28.546% |
| Teladoc Health, Inc. | 1.84 Billion USD | -41.598% |
| Universal Health Services, Inc. | 1.17 Billion USD | -121.952% |
| Veeva Systems Inc. | 1.68 Billion USD | -54.697% |
| Baxter International Inc. | 4.97 Billion USD | 47.562% |
| Becton, Dickinson and Company | 8.82 Billion USD | 70.432% |
| Intuitive Surgical, Inc. | 4.72 Billion USD | 44.84% |
| Danaher Corporation | 14.12 Billion USD | 81.536% |
| Stryker Corporation | 13.05 Billion USD | 80.022% |
| Medtronic plc | 21.27 Billion USD | 87.737% |